X-101883608-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001394560.1(ZMAT1):c.1990G>A(p.Glu664Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,205,757 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394560.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMAT1 | NM_001394560.1 | c.1990G>A | p.Glu664Lys | missense_variant | Exon 6 of 6 | ENST00000651725.2 | NP_001381489.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMAT1 | ENST00000651725.2 | c.1990G>A | p.Glu664Lys | missense_variant | Exon 6 of 6 | NM_001394560.1 | ENSP00000498446.1 |
Frequencies
GnomAD3 genomes AF: 0.00000914 AC: 1AN: 109358Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 31802
GnomAD3 exomes AF: 0.0000605 AC: 11AN: 181737Hom.: 0 AF XY: 0.0000450 AC XY: 3AN XY: 66653
GnomAD4 exome AF: 0.0000337 AC: 37AN: 1096399Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 16AN XY: 362409
GnomAD4 genome AF: 0.00000914 AC: 1AN: 109358Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 31802
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1819G>A (p.E607K) alteration is located in exon 7 (coding exon 6) of the ZMAT1 gene. This alteration results from a G to A substitution at nucleotide position 1819, causing the glutamic acid (E) at amino acid position 607 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at